
Mindpeak and DigitCells Partner to Enhance AI Pathology Workflows
DigitCells and Mindpeak have announced a strategic partnership to enhance digital pathology workflows by integrating AI algorithms, as stated in a press release. This collaboration aims to improve diagnostic accuracy and efficiency in pathology laboratories across the nation.
The partnership will see Mindpeak's AI algorithms integrated into DigitCells' advanced digital pathology platform, particularly focusing on breast cancer applications initially. The integration is expected to streamline workflows, enhance diagnostic precision, and optimize laboratory processes. A nationwide rollout of this integrated solution is planned for 2025, leveraging the infrastructure of DigitCells' parent company, GoPath Diagnostics.
Additionally, Mindpeak and GoPath Diagnostics will collaborate on developing AI tools for prostate cancer diagnostics. This effort will focus on automated tumor segmentation and scoring, aiming to improve diagnostic outcomes. The partnership also plans to expand the integration to include applications in gastrointestinal and dermatopathology by the end of the year.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more